Morgan Keegan is out with its report today on salesforce.com CRM, maintaining Outperform.
In its report, Morgan Keegan writes, "We advise investors to buy CRM shares at the current price and even more aggressively on dips because we believe its
business model is fairly well insulated from macroeconomic volatility since its applications products help enterprises generate more revenue, and its platform solutions can aid in reducing costs."
Morgan Keegan maintains a $165 PT on CRM.
At the time of posting, shares of CRM were trading at $124.41, down 2.04% from Thursday's close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in